Please enable JS

Healthcare

Title Published Pages Region Price
OpportunityAnalyzer: Vasculitis - Opportunity Analysis and Forecast to 2024 Jan 1 2016 258 Global $9,495.00
OpportunityAnalyzer: Small Cell Lung Cancer (SCLC) - Opportunity Analysis and Forecasts to 2024 Jan 1 2016 230 Global $9,495.00
PharmaPoint: Hepatitis B Virus (HBV) Therapeutics - Global Drug Forecast and Market Analysis to 2024 Jan 1 2016 323 Global $10,995.00
OpportunityAnalyzer: Pulmonary Arterial Hypertension - Opportunity Analysis and Forecast to 2024 Jan 1 2016 182 Global $9,495.00
OpportunityAnalyzer: Hodgkin’s Lymphoma (HL) - Opportunity Analysis and Forecasts to 2024 Jan 1 2016 255 Global $9,495.00
EpiCast Report: Non-Hodgkin’s Lymphoma - Epidemiology Forecast to 2024 Jan 1 2016 67 Global $3,995.00
EpiCast Report: Pulmonary Arterial Hypertension - Epidemiology Forecast to 2024 Jan 1 2016 72 Global $3,995.00
Type 2 Diabetes Mellitus Therapeutics in Asia-Pacific Markets to 2021 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth Jan 1 2016 166 Asia Pacific $4,995.00
Frontier Pharma: Parkinson’s Disease - Identifying and Commercializing First-in-Class Innovation Jan 1 2016 95 Global $6,995.00
EpiCast Report: Chronic Hepatitis B - Epidemiology Forecast to 2024 Dec 24 2015 55 Global $3,995.00
EpiCast Report: Respiratory Syncytial Virus Infection - Epidemiology Forecast to 2024 Dec 23 2015 69 Global $3,995.00
OpportunityAnalyzer: Glioblastoma - Opportunity Analysis and Forecasts to 2024 Dec 22 2015 206 Global $9,495.00
OpportunityAnalyzer: Bladder Cancer - Opportunity Analysis and Forecasts to 2017 Dec 19 2015 191 Global $9,495.00
OpportunityAnalyzer: Sjögren’s Syndrome - Opportunity Analysis and Forecast to 2024 Dec 19 2015 209 Global $9,495.00
OpportunityAnalyzer: Hepatocellular Carcinoma - Opportunity Analysis and Forecasts to 2024 Dec 17 2015 237 Global $9,495.00
PharmaPoint: Methicillin-Resistant Staphylococcus Aureus (MRSA) - Global Drug Forecast and Market Analysis to 2024 Dec 16 2015 427 Global $10,995.00
Frontier Pharma: Chronic Obstructive Pulmonary Disease (COPD) - Identifying and Commercializing First-in-Class Innovation Dec 16 2015 53 Global $6,995.00
Breast Cancer Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rapid Uptake of Premium Priced Biologics and Rising Incidence Dec 15 2015 170 Global $4,995.00
PharmaPoint: Hemophilia A and B Recombinant Factor Replacement Therapy - Global Drug Forecast and Market Analysis to 2024 Dec 11 2015 333 Global $10,995.00
OpportunityAnalyzer: Systemic Sclerosis (Scleroderma) - Opportunity Analysis and Forecast to 2024 Dec 10 2015 278 Global $9,495.00
EpiCast Report: Sjögren’s Syndrome - Epidemiology Forecast to 2024 Dec 9 2015 52 Global $3,995.00
EpiCast Report: Huntington’s Disease - Epidemiology Forecast to 2024 Dec 9 2015 49 Global $3,995.00
EpiCast Report: Systemic Sclerosis (Scleroderma) - Epidemiology Forecast to 2024 Dec 9 2015 68 Global $3,995.00
PharmaPoint: Gastric and Gastroesophageal Junction Adenocarcinoma - Global Drug Forecast and Market Analysis to 2024 Dec 9 2015 409 Global $10,995.00
EpiCast Report: Chronic Obstructive Pulmonary Disease (COPD) - Epidemiology Forecast to 2023 Dec 1 2015 73 Global $3,995.00
EpiCast Report: Brain Cancer - Epidemiology Forecast to 2024 Dec 1 2015 42 Global $3,995.00
OpportunityAnalyzer: Opioid-Induced Constipation - Opportunity Analysis and Forecasts to 2019 Dec 1 2015 166 Global $9,495.00
PharmaPoint: Meningococcal Vaccines - Global Drug Forecast and Market Analysis to 2022 Dec 1 2015 290 Global $10,995.00
OpportunityAnalyzer: Gaucher Disease - Opportunity Analysis and Forecast to 2024 Dec 1 2015 244 Global $9,495.00
OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2023 Dec 1 2015 260 Global $9,495.00

Pages